Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The drug-dispensing channel is a scarcely explored determinant of medication adherence, which is considered as a key indicator for the quality of care among patients with diabetes mellitus. In this study, we investigated the difference in adherence between diabetes patients who obtained their medication directly from a prescribing physician (physician dispensing [PD]) or via a pharmacy. METHODS: A retrospective cohort study was conducted using a large health care claims database from 2011 to 2014. Patients with diabetes of all ages and receiving at least one oral antidiabetic drug (OAD) prescription were included. We calculated patients' individual adherence to OADs defined as the proportion of days covered (PDC), which was measured over 1 year after patient identification. Good adherence was defined as PDC ≥80%. Multivariate logistic regression analysis was performed to assess the relationship between the PDC and the dispensing channel (PD, pharmacy). RESULTS: We identified a total of 10,430 patients prescribed drugs by a dispensing physician and 16,292 patients receiving drugs from a pharmacy. Medication adherence was poor in both patient groups: ~40% of the study population attained good adherence to OADs. We found no significant impact of PD on the adherence level in diabetes patients. Covariates associated significantly with good adherence were older age groups, male sex, occurrence of comorbidity and combined diabetes drug therapy. CONCLUSION: In conclusion, adherence to antihyperglycemic medication is suboptimal among patients with diabetes. The results of this study provide evidence that the dispensing channel does not have an impact on adherence in Switzerland. Certainly, medication adherence needs to be improved in both supply settings. Physicians as well as pharmacists are encouraged to develop and implement useful tools to increase patients' adherence behavior.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Suboptimal medication-taking behavior and low rates of continued medication use, or what is termed ' persistence to therapy plans, ' affects almost half of people with type 2 diabetes, leading to suboptimal glycemic and CVD risk factor control as well as increased risks of diabetes complications, mortality, and hospital admissions and increased health care costs (58 -62).”
From Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2022) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Suboptimal medication-taking behavior and low rates of continued medication use, or what is termed ' persistence to therapy plans, ' affects almost half of people with type 2 diabetes, leading to suboptimal glycemic and CVD risk factor control as well as increased risks of diabetes complications, mortality, and hospital admissions and increased health care costs (58 -62).”
From Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2022) · cites this paper as [59]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Medication Adherence: Its Importance in Cardiovascular Outcomes
Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009) · Circulation · doi:10.1161/circulationaha.108.768986 · Cited by 1,488
Long-term persistence in use of statin therapy in elderly patients
Benner, J. S. (2002) · JAMA · doi:10.1001/jama.288.4.455 · Cited by 1,232
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
Kennedy, L. (2007) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70021-0 · Cited by 1,195
Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1836 · Cited by 1,135
Adherence to diabetes medication: a systematic review
Krass, I., Schieback, P., & Dhippayom, T. (2015) · Diabetic Medicine · doi:10.1111/dme.12651 · Cited by 453 · cited 3×
“11,12 A .”
A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes
Asche, C., LaFleur, J., & Conner, C. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.01.019 · Cited by 420
Cited by
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05787-2 · Cited by 1,048
Aminde, L. N., Tindong, M., Ngwasiri, C. A., Aminde, J. A., Njim, T., Fondong, A. A., & Takah, N. F. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0360-9 · Cited by 147
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Kim, N. H., Seo, J. A., Kim, M. K., Lim, J. H., et al. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0282 · Cited by 150
Alqarni, A. M., Alrahbeni, T. M. A., AlQarni, A. M., & Qarni, H. M. A. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s176355 · Cited by 135
“On the other hand, studies from Tanzania and Switzerland showed good adherence among elderly patients likely to have multiple comorbidities when more information was provided on the benefits of adherence to medications.(32,33) Adherence to diabetic medications was found to be positively associated with a decrease in A…”
BackgroundMoon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 90
Medication adherence and self-care behaviours among patients with type 2 diabetes mellitus in Ghana
Afaya, R. A., Bam, V. B., Azongo, T. B., Afaya, A., Amponsah, A. K., Ajusiyine, J. M., & Hamid, T. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237710 · Cited by 99
“It seems evident from the review of relevant literature that similar studies have been conducted in Europe [13], Middle East [8, 12], South Africa [14], East Africa [11, 10] with limited studies in the West African sub-region [8, 9].”
BackgroundResultInfluentialAbate, T. W. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4205-4 · Cited by 33
Amerzadeh, M., Kisomi, Z. S., Senmar, M., Khatooni, M., Hosseinkhani, Z., & Bahrami, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-70000-w · Cited by 32
Vlacho, B., Simarro, F. L., Mata‐Cases, M., Miravet-Jiménez, S., Escribano‐Serrano, J., Asensio, D., Cortés, X., & Franch‐Nadal, J. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.10.004 · Cited by 30
Horvat, O., Popržen, J., Tomás, A., Kusturica, M. P., Tomić, Z., & Sabo, A. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.10.002 · Cited by 26
Issues and challenges in diabetic neuropathy management: A narrative review
Ismail, C. A. N. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i6.741 · Cited by 31
A Qualitative Study on Medication Taking Behaviour Among People With Diabetes in Australia
Ahmad, A., Khan, M. U., & Aslani, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.693748 · Cited by 22
Aiyappan, R., Aravindakshan, R., & Abraham, S. (2021) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_985_20 · Cited by 24
Khassawneh, A., Alzoubi, A., Khasawneh, A. G., Abdo, N. M., Abu‐Naser, D., Al-Mistarehi, A.-H. W., Albattah, M. F., & Kheirallah, K. A. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13777 · Cited by 15
Alfulayw, M. R., Almansour, R. A., Aljamri, S. K., Ghawas, A. H., Alhussain, S. S., Althumairi, A. A., Almuthaffar, A. A., Alhuwayji, K. A., Almajed, A. A., Al-Yateem, S. S., et al. (2022) · Cureus · doi:10.7759/cureus.31965 · Cited by 10
Development and Validation of the Real-World Progression in Diabetes (RAPIDS) Model
Basu, A., Sohn, M., Bartle, B., Chan, K. C. G., Cooper, J. M., & Huang, E. S. (2019) · Medical Decision Making · doi:10.1177/0272989x18817521 · Cited by 10
Patient preferences for the treatment of type 2 diabetes in Australia: a discrete choice experiment
Ahmad, A., Khan, M. U., & Aslani, P. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00962-5 · Cited by 9
Singh, H., Singh, J., Bhangu, R. K., Singla, M., Singh, J., & Javid, F. A. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2163386 · Cited by 10
“Many patients with DM tend to adhere poorly to their antihyperglycemic medications [5,6].”
BackgroundArellano, A. A. S., Contreras, G. N., Blázquez, F. P., & Torres, C. E. C. (2020) · Nova Scientia · doi:10.21640/ns.v12i25.2466 · Cited by 9
“La baja adherencia terapéutica tiene como consecuencia directa una alta prevalencia de padecimientos comórbidos que afectan la calidad de vida de los individuos (Boye, Curtis, Lage & García-Pérez, 2016; Huber & Reich, 2016).”
BackgroundLuo, L., Chen, X., Xie, H., Zhou, J., & Li, L. (2023) · BMC Nursing · doi:10.1186/s12912-023-01326-5 · Cited by 6
Jaya, A. M., Harries, A. D., Rahman, A., Khogali, M. A., Chinnakali, P., & Gopal, B. K. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7060104 · Cited by 5
Kassaw, A. T., Baye, T., Derbie, A., Ashagrie, G., Girmaw, F., & Kassie, A. M. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-093413 · Cited by 4
Abhilash, P., Dsouza, D. J., Sradha, S. K., Nandakumar, U. P., Ahmed, S., Kolar, R., & Chand, S. (2023) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2023.100163 · Cited by 9
Hamalaw, S. A., Salih, A. H. S. H., & Weli, S. M. (2024) · Cureus · doi:10.7759/cureus.60572 · Cited by 4
“[10].”
Rachamin, Y., Meier, R., Valeri, F., Rosemann, T. J., & Muheim, L. (2021) · Health Policy · doi:10.1016/j.healthpol.2021.07.014 · Cited by 4
Alresheedi, W., & Rabbani, U. (2022) · Medical Science · doi:10.54905/disssi/v26i122/ms134e2130 · Cited by 3
Luo, H., Yin, L., Li, J., & Xu, W. (2021) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v20i1.26 · Cited by 3
“These findings are similar to those obtained earlier in a retrospective cohort study [15] and in cross-sectional studies [16,17].”
BackgroundResultEsposti, L. D., Perrone, V., Saragoni, S., Blini, V., Buda, S., D’avella, R., Gasperini, G., Lena, F., Fanelli, F., Gazzi, L., et al. (2019) · Journal of Diabetes Research · doi:10.1155/2019/3174654 · Cited by 2
“Adherence to antidiabetes medications is crucial to reach metabolic control, since nonadherence is associated with increased levels of HbA1c as well as other negative outcomes such as increased LDL cholesterol levels, frequent hospitalizations, and mortality [34].”
BackgroundMohammed, A. G., Alibrahim, N. T. Y., & Al-Waeli, D. K. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/6659722 · Cited by 3
“Themedian duration of diabetes among study participants was 5 years, indicating that most patients had been living with T2DM for a considerable period, which may in fl uence medication adherence and disease management [11].”
Medication Adherence in Patients with Diabetes Mellitus and Influencing Factors in Indonesia
Lestari, P., Liyanovitasari, & Prabowo, H. (2025) · Diabetes Mellitus · doi:10.14341/dm13068 · Cited by 1
Khamees, A. B., Arabyat, R. M., Alabbadi, I., & Alnahar, S. A. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s532590 · Cited by 1
“P values less than 0.05 were considered as statistically significant.”
Influential11 Tipps, um Diabetiker bei der Stange zu halten
Kulzer, B. (2017) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-017-9343-9 · Cited by 1
Medication Adherence Rates of Marshallese Patients Treated in a Student-Led Free Clinic
Hudson, J. S., Balli, M. L., Purvis, R. S., Selig, J. P., Warmack, T. S., Schulz, T., Coulter, L., Peter, C., & McElfish, P. A. (2020) · Journal of Student-Run Clinics · doi:10.59586/jsrc.v6i1.163 · Cited by 1
Abramsson, L., & Gustafsson, M. V. (2018) · Pharmacy · doi:10.3390/pharmacy6010020 · Cited by 1
“However, in a large study on medication adherences in patients with diabetes from Switzerland, no impact of dose dispensing systems on medication adherence was observed [23].”
BackgroundLoh, F. E. (2020) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2020.12.555848 · Cited by 1
Hamzah, I. H., Saeed, N. A.-H. A. A. H., & Al-Kadmy, I. M. S. (2022) · Iraqi Journal of Industrial Research · doi:10.53523/ijoirvol9i2id192
“The findings of study were similar to the study conducted by Carole and Oliver (10) the result revealed that a total of 10,430 patients prescribed drugs by a dispensing physician and 16,292 patients received drugs from a pharmacy.”
ResultJarujumrus, I. (2020) · Chula Digiverse · doi:10.58837/chula.the.2020.428
Determinants of older people's preferences for dispensing doctors
Richter, L., & Hartmann, V. (2020) · Journal of Nursing Social Studies Public Health and Rehabilitation · doi:10.32725/jnss.2020.009
“…et al., 2004; Kaiser and Schmid, 2016; Reich et al., 2012; Trottmann et al., 2016; Wilcock, 2001) and to the effectiveness of dispensing regimes (Lim et al., 2014) e.g. in the prevention of adverse events (Blozik et al., 2015; Meyer, 2016; Munger et al., 2014) or adherence (Huber and Reich, 2016).”
Nerve Under Siege: Managing Diabetic Neuropathy and Pain
Alom, S., Ali, F., Abubakar, M., Yogi, S., & Bhat, H. R. (2026) · Springer eBooks · doi:10.1007/978-981-95-8946-3_3
Metadata
- Authors
- Huber, C. A., & Reich, O.
- Affiliations
- Helsana Group (Switzerland) (CH)
- Corresponding author
- Huber, Carola A
- ORCID
- Huber, Carola A
- Venue
- Patient Preference and Adherence
- Publisher
- Informa UK Limited
- Published
- 2016-09
- Volume
- Volume 10
- Pages
- 1803-1809
- ISSN
- 1177-889X (ISSN-L)
- PMC
- PMC5029845
- OpenAlex
- W2520169821
- Cited by
- 42
- References
- 27
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 9 · 2021: 4 · 2020: 7 · 2019: 4 · 2018: 4 · 2017: 2
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Patient Preference and Adherence (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- medication adherence, diabetes mellitus, oral antidiabetic drugs, physician dispensing, medication dispensing, quality of care, proportion of days covered, comorbidities, antihyperglycemic medications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
